Life Science Company News

Reset
Results 421 - 440 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »

Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Evaxion Biotech A/S

Femasys Announces First-Patient-In for Pivotal Clinical Trial Evaluating its FemBloc Permanent Birth Control

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Femasys Inc.

LIXTE Biotechnology Announces a Supported Collaborative Trial to Study LIXTE’s First-in-Class PP2A Inhibitor, LB-100, Plus GSK’s Immunotherapy, Dostarlimab, in Clear-Cell Ovarian Cancer

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Lixte Biotechnology Holdings, Inc

Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Inozyme Pharma

Protara Therapeutics Announces Dosing of First Patient in Phase 1b/2 ADVANCED-2 Trial of TARA-002 in NMIBC Patients with High Grade Carcinoma in Situ

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Protara Therapeutics, Inc.

Veru to Participate in Fireside Chat at the 2023 Cantor Fitzgerald Global Healthcare Conference on September 28th, 2023

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Veru Inc.

Lucy Scientific Discovery (NASDAQ: LSDI) Leverages Power of M&A to Capitalize on Synergistic Growth

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Lucy Scientific Discovery Inc.

Inhibikase Therapeutics Issues a Letter to Shareholders and Comments on Recent Trading Activity

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Inhibikase Therapeutics, Inc.

Parexel’s Amy McKee, M.D. Named to 2023 PharmaVoice 100

Read more ››
By: GlobeNewswire - 20 Sep 2023

The Nation’s Largest Private Academic Plastic Surgery Practice Continues to Expand with the Addition of Two Surgeons

Read more ››
By: GlobeNewswire - 20 Sep 2023

New Research From Inovalon and Harvard Uncovers Utilization and Cost Differences Between Medicare Advantage and Traditional Medicare

Read more ››
By: GlobeNewswire - 20 Sep 2023

Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Cytek Biosciences Inc.

Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm™ (epinephrine) Sublingual Film

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Aquestive Therapeutics, Inc.

PolyPid Announces Reverse Share Split

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  PolyPid Ltd.

OnKure Therapeutics Appoints Ann Howell, Pharm.D., as Vice President of Regulatory Affairs

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  OnKure, Inc.

RadNet, Inc. to Present at the Sidoti & Company Fall 2023 Virtual Conference on Wednesday, September 20th

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  RadNet, Inc

TOWER ONE WIRELESS UPDATE ON FILINGS AND LISTING

Read more ››
By: GlobeNewswire - 20 Sep 2023

World Leaders in Proteomics and Genomics to Convene at the 2nd International Top-Down Proteomics Symposium

Read more ››
By: GlobeNewswire - 20 Sep 2023

Guerbet: 2023 half-year results

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Guerbet SA

Pixium Vision announces the completion of the reverse stock split of its shares on the basis of 1 new share for 50 existing shares and the start of trading of the shares resulting after the completion of the reverse split as of Sep 21, 2023

Read more ››
By: GlobeNewswire - 20 Sep 2023
Related companies:  Pixium Vision S.A.
Results 421 - 440 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »